Staff Profile

Appointments

• Consultant in Paediatric and Adolescent Oncology / BMT, Newcastle upon Tyne Hospitals NHS Foundation Trust
• Honorary Professor of Childhood Cancer, Northern Institute of Cancer Research, University of Newcastle

Qualifications

• BSc (Hons, 2[1]) in Physiology (Birmingham)   1980
• MB,ChB (Hons) (Birmingham)   1983
• MRCP (UK) (General Medicine)   1986
• DCH (London)   1987
• Ph D (Newcastle)   1995
• FRCPCH   1997

Leading professional roles

• Founding member (2008) of Pan-European Network for Care of Survivors after Childhood and Adolescent Cancer (PanCare)
• Member of Executive Board of PanCare 2008 - 2019 and 2020 - 2023
• Member of Core Group of International Late Effects of Childhood Cancer Guideline Harmonization Group 2010 -
• Chair of Children’s Cancer and Leukaemia Group (CCLG) Supportive Care Group (2003-08)
• Chair of CCLG / UK Paediatric Bone Marrow Transplant Group (2008-2012)
• Current chair of CCLG Late Effects Group (since 2016)

Area of expertise

• Late effects of childhood cancer / bone marrow transplant
• Long-term follow-up of childhood cancer survivors / bone marrow transplant
• Cancer survivorship

Research interests

Late adverse effects of treatment for childhood / adolescent malignancy and bone marrow transplantation (BMT)

Evidence-based guideline development for surveillance for late adverse effects

Long-term follow-up of childhood / adolescent malignancy / BMT survivors

Survivorship after childhood / adolescent malignancy / BMT

Acute toxicity of treatment for childhood / adolescent malignancy / BMT

Immunisation of children / adolescents with malignancy or after BMT

Funding

European Union FP7 programme

Children with Cancer UK

Special Trustees (Newcastle Healthcare Charity)

Children's Cancer Fund

Children's Cancer and Leukaemia Group

• Verbruggen LC, Hudson MM, Bowers DC, Ronckers CM, Armstrong GT, Skinner R, Hoving EW, Janssens GO, van der Pal HJH, Kremer LCM, Mulder RL. Variations in screening and management practices for subsequent asymptomatic meningiomas in childhood, adolescent and young adult cancer survivors. Journal of Neuro-Oncology 2020, 147, 417-425.
• Michel G, Mulder RL, van der Pal HJH, Skinner R, Bardi E, Brown MC, Vetsch J, Frey E, Windsor R, Kremer LCM, Levitt G. Evidence-based recommendations for the organization of long-term follow-up care for childhood and adolescent cancer survivors: a report from the PanCareSurFup Guidelines Working Group. Journal of Cancer Survivorship 2019, 13, 759-772.
• Clemens E, van den Heuvel-Eibrink MM, Mulder RL, Kremer LCM, Hudson MM, Skinner R, Constine LS, Bass JK, Kuehni CE, Langer T, van Dalen EC, Bardi E, Bonne N-X, Brock PR, Brooks B, Carleton B, Caron E, Chang KW, Johnston K, Knight K, Nathan PC, Orgel E, Prasad PK, Rottenberg J, Scheinemann K, de Vries ACH, Walwyn T, Weiss A, am Zehnhoff-Dinnesen A, Cohn RJ, Landier W. Recommendations for ototoxicity surveillance for childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCare Consortium. The Lancet Oncology 2019, 20(1), e29-e41.
• Allodji RS, Hawkins MM, Bright CJ, Fidler-Benaoudia MM, Winter DL, Alessi D, Fresneau B, Journy N, Morsellino V, Bardi E, Bautz A, Byrne J, Feijen ELA, Teepen JC, Vu-Bezin G, Rubino C, Garwicz S, Grabow D, Gudmundsdottir T, Guha J, Hau E-M, Jankovic M, Kaatsch P, Kaiser M, Linge H, Muraca M, Llanas D, Veres C, Ofstaas H, Diallo I, Mansouri I, Ronckers CM, Skinner R, Terenziani M, Wesenberg F, Wiebe T, Sacerdote C, Jakab Z, Haupt R, Lahteenmaki P, Zaletel LZ, Kuehni CE, Winther JF, Michel G, Kremer LCM, Hjorth L, Haddy N, de Vathaire F, Reulen RC. Risk of subsequent primary leukaemias among 69,460 five-year survivors of childhood cancer diagnosed from 1940 to 2008 in Europe: A cohort study within PanCareSurFup. European Journal of Cancer 2019, 117, 71-83.
• Clement SC, Kremer LCM, Verburg FA, Simmons JH, Goldfarb M, Peeters RP, Alexander EK, Bardi E, Brignardello E, Constine LS, Dinauer CA, Drozd VM, Felicetti F, Frey E, Heinzel A, van den Heuvel-Eibrink MM, Huang SA, Links TP, Lorenz K, Mulder RL, Neggers SJ, Nieveen van Dijkum EJM, Oeffinger KC, van Rijn RR, Rivkees SA, Ronckers CM, Schneider AB, Skinner R, Wasserman JD, Wynn T, Hudson MM, Nathan PC, van Santen HM. Balancing the benefits and harms of thyroid cancer surveillance in survivors of Childhood, adolescent and young adult cancer: Recommendations from the international Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium. Cancer Treatment Reviews 2018, 63, 28-39.
• Kenney LB, Antal Z, Ginsberg JP, Hoppe BS, Bober SL, Yu RN, Constine LS, van Santen HM, Skinner R, Green DM. Improving male reproductive health after childhood, adolescent, and young adult cancer: Progress and future directions for survivorship research. Journal of Clinical Oncology 2018, 36(21), 2160-2168.
• Skinner R. Late renal toxicity of treatment for childhood malignancy: risk factors, long-term outcomes, and surveillance. Pediatric Nephrology 2018, 33(2), 215-225.
• Jankovic M, Haupt R, Spinetta JJ, Beck JD, Byrne J, Calaminus G, Lackner H, Biondi A, Oeffinger K, Hudson M, Skinner R, Reaman G, van der Pal H, Kremer L, Den Hartogh J, Michel G, Frey E, Bardi E, Hawkins M, Rizvi K, Terenziani M, Valsecchi MG, Bode G, Jenney M, de Vathaire F, Garwicz S, Levitt GA, Grabow D, Kuehni CE, Schrappe M, Hjorth L. Long-term survivors of childhood cancer: cure and care - the Erice Statement (2006) revised after 10 years (2016). Journal of Cancer Survivorship 2018, 12(5), 647-650.
• Tonorezos ES, Barnea D, Cohn RJ, Cypriano MS, Fresneau BC, Haupt R, Hjorth L, Ishida Y, Kruseova J, Kuehni CE, Kurkure PA, Langer T, Nathan PC, Skeen JE, Skinner R, Tacyildiz N, Van Den Heuvel-Eibrink MM, Winther JF, Hudson MM, Oeffinger KC. Models of care for survivors of childhood cancer from across the globe: Advancing survivorship care in the next decade. Journal of Clinical Oncology 2018, 36(21), 2223-2230.
• Unni MNM, Elfeky R, Rao K, Nademi Z, Chiesa R, Amrolia P, Skinner R, Slater O, Worth A, Flood T, Abinun M, Hambleton S, Qasim W, Gaspar HB, Cant AJ, Gennery AR, Veys P, Slatter MA. Non-posttransplant lymphoproliferative disorder malignancy after hematopoietic stem cell transplantation in patients with primary immunodeficiency: UK experience. Journal of Allergy and Clinical Immunology 2018, 141(6), 2319-2321.e1.
• Bate J, Baker S, Breuer J, Chisholm JC, Gray J, Hambleton S, Houlton A, Jit M, Lowis S, Makin G, O'Sullivan C, Patel SR, Phillips R, Ransinghe N, Ramsay ME, Skinner R, Wheatley K, Heath PT. PEPtalk2: Results of a pilot randomised controlled trial to compare VZIG and aciclovir as postexposure prophylaxis (PEP) against chickenpox in children with cancer. Archives of Disease in Childhood 2018, 104(1), 25-29.
• Landier W, Skinner R, Wallace WH, Hjorth L, Mulder RL, Wong FL, Yasui Y, Bhakta N, Constine LS, Bhatia S, Kremer LC, Hudson MM. Surveillance for late effects in childhood cancer survivors. Journal of Clinical Oncology 2018, 36(21), 2216-2222.
• Shah RM, Elfeky R, Nademi Z, Qasim W, Amrolia P, Chiesa R, Rao K, Lucchini G, Silva JMF, Worth A, Barge D, Ryan D, Conn J, Cant AJ, Skinner R, Abd Hamid IJ, Flood T, Abinun M, Hambleton S, Gennery AR, Veys P, Slatter M. T-cell receptor αβ+ and CD19+ cell-depleted haploidentical and mismatched hematopoietic stem cell transplantation in primary immune deficiency. Journal of Allergy and Clinical Immunology 2018, 141(4), 1417-1426.e1.
• Byrne J, Alessi D, Allodji RS, Bagnasco F, Bardi E, Bautz A, Bright CJ, Brown M, Diallo I, Feijen EAML, Fidler MM, Frey E, Garwicz S, Grabow D, Gudmundsdottir T, Hagberg O, Harila-Saari A, Hau EM, Haupt R, Hawkins MM, Jakab Z, Jankovic M, Kaatsch P, Kaiser M, Kremer LCM, Kuehni CE, Kuonen R, Ladenstein R, Lahteenmaki PM, Levitt G, Linge H, LLanas D, Michel G, Morsellino V, Mulder RL, Reulen RC, Ronckers CM, Sacerdote C, Skinner R, Steliarova-Foucher E, van der Pal HJ, de Vathaire F, Vu Bezin G, Wesenberg F, Wiebe T, Winter DL, Falck Winther J, Witthoff E, Zadravec Zaletel L, Hjorth L. The PanCareSurFup consortium: research and guidelines to improve lives for survivors of childhood cancer. European Journal of Cancer 2018, 103, 238-248.
• Flinn AM, Roberts CF, Slatter MA, Skinner R, Robson H, Lawrence J, Guest J, Gennery AR. Thymopoiesis following HSCT; a retrospective review comparing interventions for aGVHD in a pediatric cohort. Clinical Immunology 2018, 193, 33-37.
• Skinner R, Mulder RL, Kremer LC, Hudson MM, Constine LS, Bardi E, Boekhout A, Borgmann-Staudt A, Brown MC, Cohn R, Dirksen U, Giwercman A, Ishiguro H, Jahnukainen K, Kenney LB, Loonen JJ, Meacham L, Neggers S, Nussey S, Petersen C, Shnorhavorian M, van den Heuvel-Eibrink MM, van Santen HM, Wallace WHB, Green DM. Recommendations for gonadotoxicity surveillance in male childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium. The Lancet Oncology 2017, 18(2), e75-e90.
• Heimall J, Buckley RH, Puck J, Fleisher TA, Gennery AR, Haddad E, Neven B, Slatter M, Skinner R, Baker KS, Dietz AC, Duncan C, Griffith LM, Notarangelo L, Pulsipher MA, Cowan MJ. Recommendations for Screening and Management of Late Effects in Patients with Severe Combined Immunodeficiency after Allogenic Hematopoietic Cell Transplantation: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT. Biology of Blood and Marrow Transplantation 2017, 23(8), 1229-1240.
• Forster VJ, van Delft FW, Baird SF, Mair S, Skinner R, Halsey C. Reply: Methotrexate neurotoxicity due to drug interactions: an inadequate folinic acid effect. Cancer Chemotherapy and Pharmacology 2017, 79(4), 841-842.
• Dietz AC, Duncan CN, Alter BP, Bresters D, Cowan MJ, Notarangelo L, Rosenberg PS, Shenoy S, Skinner R, Walters MC, Wagner J, Baker KS, Pulsipher MA. The Second Pediatric Blood and Marrow Transplant Consortium International Consensus Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: Defining the Unique Late Effects of Children Undergoing Hematopoietic Cell Transplantation for Immune Deficiencies, Inherited Marrow Failure Disorders, and Hemoglobinopathies. Biology of Blood and Marrow Transplantation 2017, 23(1), 24-29.
• Flinn A, Slatter M, Skinner R, Robson H, Cooper J, Guest J, Gennery A. A Retrospective Review of a Cohort of Paediatric Patients Treated with ECP for the Management of GVHD. In: 42nd Annual Meeting of the European Society for Blood and Marrow Transplantation. 2016, Valencia, Spain: Nature Publishing Group.
• Tresman R, Brown M, Fraser F, Skinner R, Bailey S. A School Passport as Part of a Protocol to Assist Educational Reintegration After Medulloblastoma Treatment in Childhood. Pediatric Blood & Cancer 2016, 63(9), 1636-1642.
• Skinner R, von Zglinicki T. Accelerated Aging in Bone Marrow Transplant Survivors. JAMA Oncology 2016, 2(10), 1267-1268.
• Mulla H, Buck H, Price L, Parry A, Bell G, Skinner R. 'Acceptability' of a new oral suspension formulation of mercaptopurine in children with acute lymphoblastic leukaemia. Journal of Oncology Pharmacy Practice 2016, 22(3), 387-395.
• Baird R, Banks I, Cameron D, Chester J, Earl H, Flannagan M, Januszewski A, Kennedy R, Payne S, Samuel E, Taylor H, Agarwal R, Ahmed S, Archer C, Board R, Carser J, Copson E, Cunningham D, Coleman R, Dangoor A, Dark G, Eccles D, Gallagher C, Glaser A, Griffiths R, Hall G, Hall M, Harari D, Hawkins M, Hill M, Johnson P, Jones A, Kalsi T, Karapanagiotou E, Kemp Z, Mansi J, Marshall E, Mitchell A, Moe M, Michie C, Neal R, Newsom-Davis T, Norton A, Osborne R, Patel G, Radford J, Ring A, Shaw E, Skinner R, Stark D, Turnbull S, Velikova G, White J, Young A, Joffe J, Selby P. An Association of Cancer Physicians' strategy for improving services and outcomes for cancer patients. ecancermedicalscience 2016, 10, 608.
• Dignan FL, Clark A, Aitken C, Gilleece M, Jayakar V, Krishnamurthy P, Pagliuca A, Potter MN, Shaw B, Skinner R, Turner A, Wynn RF, Coyle P. BCSH/BSBMT/UK clinical virology network guideline: Diagnosis and management of common respiratory viral infections in patients undergoing treatment for haematological malignancies or stem cell transplantation. British Journal of Haematology 2016, 173(3), 380-393.
• Tresman R, Fraser F, Brown M, Skinner R, Bailey S. Developing A Model Of Reintegration Into Education Post-Medulloblastoma Treatment In Children: A Thematic Analysis. In: 17th International Symposium on Pediatric Neuro-Oncology (ISPNO). 2016, Liverpool: Oxford University Press.
• Forster VJ, van Delft FW, Baird SF, Mair S, Skinner R, Halsey C. Drug interactions may be important risk factors for methotrexate neurotoxicity, particularly in pediatric leukemia patients. Cancer Chemotherapy and Pharmacology 2016, 78(5), 1093-1096.
• Boztug H, Sykora K-W, Slatter M, Zecca M, Veys P, Lankester A, Cant A, Skinner R, Wachowiak J, Glogova E, Pötschger U, Peters C. European Society for Blood and Marrow Transplantation Analysis of Treosulfan Conditioning Before Hematopoietic Stem Cell Transplantation in Children and Adolescents With Hematological Malignancies. Pediatric Blood & Cancer 2016, 63(1), 139-148.
• Slatter M, Nademi Z, Leahy TR, Morillo-Gutierrez B, Dunn J, Barge D, Skinner R, Ryan C, Hambleton S, Abinun M, Flood T, Cant A, Gennery A. Haploidentical CD3 TCRαβ and CD19-depleted second stem cell transplant for steroid-resistant acute skin graft versus host disease. Journal of Allergy and Clinical Immunology 2016, 138(2), 603-605.
• Mayes J, Brown MC, Davies N, Skinner R. Health promotion and information provision during long-term follow-up for childhood cancer survivors: a service evaluation. Pediatric Hematology and Oncology 2016, 33(6), 359-370.
• Bresters D, Lawitschka A, Cugno C, Potschger U, Dalissier A, Michel G, Vettenranta K, Sundin M, Al-Seraihy A, Faraci M, Sedlacek P, Versluys AB, Jenkins A, Lutz P, Gibson B, Leiper A, Diaz MA, Shaw PJ, Skinner R, O'Brien TA, Salooja N, Bader P, Peters C. Incidence and severity of crucial late effects after allogeneic HSCT for malignancy under the age of 3 years: TBI is what really matters. Bone Marrow Transplantation 2016, 51(11), 1482-1489.
• Feijen EAM, Font-Gonzalez A, van Dalen EC, van der Pal HJH, Reulen RC, Winter DL, Kuehni CE, Haupt R, Alessi D, Byrne J, Bardi E, Jakab Z, Grabow D, Garwicz S, Jankovic M, Levitt GA, Skinner R, Zaletel LZ, Hjorth L, Tissing WJE, de Vathaire F, Hawkins MM, Kremer LCM, PanCareSurFup Consortium. Late Cardiac Events after Childhood Cancer: Methodological Aspects of the Pan-European Study PanCareSurFup. PLOS One 2016, 11(9), e0162778.
• Fidler MM, Reulen RC, Winter DL, Kelly J, Jenkinson HC, Skinner R, Frobisher C, Hawkins MM, British Childhood Canc Survivor. Long term cause specific mortality among 34489 five year survivors of childhood cancer in Great Britain: population based cohort study. BMJ 2016, 354, i4351.
• van Dorp W, Mulder RL, Kremer LCM, Hudson MM, van den Heuvel-Eibrink MM, van den Berg MH, Levine JM, van Dulmen-den Broeder E, di Iorgi N, Albanese A, Armenian SH, Bhatia S, Constine LS, Corrias A, Deans R, Dirksen U, Gracia CR, Hjorth L, Kroon L, Lambalk CB, Landier W, Levitt G, Leiper A, Meacham L, Mussa A, Neggers SJ, Oeffinger KC, Revelli A, van Santen HM, Skinner R, Toogood A, Wallace WH, Haupt R. Recommendations for Premature Ovarian Insufficiency Surveillance for Female Survivors of Childhood, Adolescent, and Young Adult Cancer: A Report From the International Late Effects of Childhood Cancer Guideline Harmonization Group in Collaboration With the PanCareSurFup Consortium. Journal of Clinical Oncology 2016, 34(28), 3440-3450.
• Guest J, Cheal H, Lawrence J, Gennery A, Skinner R. The development of a Nurse-Led Clincal Apheresis service in extra-corporeal photopheresis (ECP) for the treatment of small body weight patients. In: 42nd Annual Meeting of the European Society for Blood and Marrow Transplantation. 2016, Valencia, Spain: Nature Publishing Group.
• Brown MC, Pearce MS, Bailey S, Skinner R. The long-term psychosocial impact of cancer: the views of young adult survivors of childhood cancer. European Journal of Cancer Care 2016, 25(3), 428-439.
• Ryan SL, Matheson E, Grossmann V, Sinclair P, Bashton M, Schwab C, Towers W, Partington M, Elliott A, Minto L, Richardson S, Rahman T, Keavney B, Skinner R, Bown N, Haferlach T, Vandenberghe P, Haferlach C, Santibanez-Koref M, Moorman AV, Kohlmann A, Irving JA, Harrison CJ. The role of the RAS pathway in iAMP21-ALL. Leukemia 2016, 30, 1824-1831.
• Mulder RL, van der Pal HJH, Levitt GA, Skinner R, Kremer LCM, Brown MC, Bardi E, Windsor R, Michel G, Frey E. Transition guidelines: An important step in the future care for childhood cancer survivors. A comprehensive definition as groundwork. European Journal of Cancer 2016, 54, 64-68.
• Wynn RF, Veys P, Steward CG, Vora A, Skinner R, Gibson B, Velangi M, Hough R, Potter M, de la Fuente J, Amrolia P, Smith O. "We Can Work It out": The Development of a Consensus Approach to Decision Making in Allogeneic Stem Cell Transplantation in the UK. In: 2015 BMT Tandem Meetings. 2015, San Diego, CA: Elsevier.
• Winther JF, Kenborg L, Byrne J, Hjorth L, Kaatsch P, Kremer LCM, Kuehni CE, Auquier P, Michel G, de Vathaire F, Haupt R, Skinner R, Madanat-Harjuoja LM, Tryggvadottir L, Wesenberg F, Reulen RC, Grabow D, Ronckers CM, van Dulmen-den Broeder E, van den Heuvel-Eibrink MM, Schindler M, Berbis J, Holmqvist AS, Gudmundsdottir T, Licht SD, Bonnesen TG, Asdahl PH, Bautz A, Kristoffersen AK, Himmerslev L, Hasle H, Olsen JH, Hawkins MM. Childhood cancer survivor cohorts in Europe. Acta Oncologica 2015, 54(5), 655-668.
• Brown M, Pearce M, Skinner R. Developing and piloting a questionnaire to investigate important psychosocial outcomes in survivors of childhood and adolescent cancer. In: British Psychosocial Oncology Society 2015 Annual Conference. 2015, Leeds, UK: Wiley.
• Boztug H, Glogova E, Potschger U, Zecca M, Veys P, Lankester A, Cant A, Skinner R, Slatter M, Wachowiak J, Sykora KW, Peters C, EBMT Pediatric Dis Working Party. EBMT metaanalysis of treosulfan conditioning before allogeneic hematopoietic stem cell transplantation in paediatric patients with haematological malignancies. In: 41st Annual Meeting of the European Society for Blood and Marrow Transplantation. 2015, Istanbul, Turkey: Nature Publishing Group.
• Wong K, Reulen R, Bright C, Winter D, Guha J, Fidler M, Kelly J, Frobisher C, Skinner R, Hawkins M. Long-term renal morbidity in survivors of childhood cancer in the British Childhood Cancer Survivor Study (BCCSS) using data from the national Hospital Episode Statistics database. In: National Cancer Intelligence Network Cancer Outcomes Conference 2015. 2015, Belfast, Northern Ireland: Wiley-Blackwell.
• Strehle EM, Straub V. Recent advances in the management of Duchenne muscular dystrophy. Archives of Disease in Childhood 2015, 100(12), 1173-1177.
• Armenian SH, Hudson MM, Mulder RL, Chen MH, Constine LS, Dwyer M, Nathan PC, Tissing WJE, Shankar S, Sieswerda E, Skinner R, Steinberger J, van Dalen EC, van der Pal H, Wallace WH, Levitt G, Kremer LCM. Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncology 2015, 16(3), E123-E136.
• Bomken S, Skinner R. Second Malignant Neoplasms Following Haematopoietic Stem Cell Transplantation in Childhood. Children 2015, 2(2), 146-173.
• Dufour C, Veys P, Carraro E, Bhatnagar N, Pillon M, Wynn R, Gibson B, Vora AJ, Steward CG, Ewins AM, Hough RE, de la Fuente J, Velangi M, Amrolia PJ, Skinner R, Bacigalupo A, Risitano AM, Socie G, de Latour RP, Passweg J, Rovo A, Tichelli A, Schrezenmeier H, Hochsmann B, Bader P, van Biezen A, Aljurf MD, Kulasekararaj A, Marsh JC, Samarasinghe S. Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of EBMT. British Journal of Haematology 2015, 171(4), 585-594.
• Holzinger D, Fassl SK, de Jager W, Lohse P, Rohrig UF, Gattorno M, Omenetti A, Chiesa S, Schena F, Austermann J, Vogl T, Kuhns DB, Holland SM, Rodriguez-Gallego C, Lopez-Almaraz R, Arostegui JI, Colino E, Roldan R, Fessatou S, Isidor B, Poignant S, Ito K, Epple HJ, Bernstein JA, Jeng M, Frankovich J, Lionetti G, Church JA, Ong PY, LaPlant M, Abinun M, Skinner R, Bigley V, Sachs UJ, Hinze C, Hoppenreijs E, Ehrchen J, Foell D, Chae JJ, Ombrello A, Aksentijevich I, Sunderkoetter C, Roth J. Single amino acid charge switch defines clinically distinct proline-serine-threonine phosphatase-interacting protein 1 (PSTPIP1)-associated inflammatory diseases. Journal of Allergy and Clinical Immunology 2015, 136(5), 1337-1345.
• Hjorth L, Haupt R, Skinner R, Grabow D, Byrne J, Karner S, Levitt G, Michel G, van der Pal H, Bardi E, Beck JD, de Vathaire F, Essig S, Frey E, Garwicz S, Hawkins M, Jakab Z, Jankovic M, Kazanowska B, Kepak T, Kremer L, Lackner H, Sugden E, Terenziani M, Zaletel LZ, Kaatsch P, PanCare Network. Survivorship after childhood cancer: PanCare: A European Network to promote optimal long-term care. European Journal of Cancer 2015, 51(10), 1203-1211.
• Brown M, Pearce M, Bailey S, Skinner R. The long-term psychosocial impact of cancer - the views of young adult survivors of childhood and adolescent cancer. In: British Psychosocial Oncology Society 2015 Annual Conference. 2015, Leeds, UK: Wiley-Blackwell.
• Brown MC, Levitt GA, Frey E, Bárdi E, Haupt R, Hjorth L, Kremer L, Kuehni CE, Lettner C, Mulder RL, Michel G, Skinner R. The views of European clinicians on guidelines for long-term follow-up of childhood cancer survivors. Pediatric Blood & Cancer 2015, 62(2), 322–328.
• Boztug H, Zecca M, Sykora KW, Veys P, Lankester A, Slatter M, Skinner R, Wachowiak J, Potschger U, Glogova E, Peters C, EBMT Paediat Dis Working Party. Treosulfan-based conditioning regimens for allogeneic HSCT in children with acute lymphoblastic leukaemia. Annals of Hematology 2015, 94(2), 297-306.
• Gupta V, Bourne D, Bown N, Samarasinghe S, Bailey S, Skinner R. FLT3 internal tandem duplication and NPM1 mutations in paediatric AML: a single centre experience. In: 46th Congress of the International Society of Paediatric Oncology (SIOP) 2014. 2014, Toronto, Canda: Wiley-Blackwell.
• Dhir S, Slatter M, Skinner R. Recent advances in the management of graft-versus-host disease. Archives of Disease in Childhood 2014, 99(12), 1150-1157.
• Dufour C, Pillon M, Carraro E, Bhatnagar N, Wynn R, Gibson B, Vora AJ, Steward CG, Ewins AM, Hough RE, de la Fuente J, Velangi M, Veys P, Amrolia PJ, Skinner R, Bacigalupo A, Risitano AM, Socie G, de Latour RP, Passweg J, Rovo A, Tichelli A, Schrezenmeier H, Hochsmann B, Bader P, van Biezen A, Marsh JC, Aljurf MD, Samarasinghe S. Similar Outcome of Upfront Unrelated and Matched Sibling Donor Hematopoietic Stem Cell Transplantation in Idiopathic Anlastic Anaemia of Childhood and Adolescence: A Cohort Controlled Study on Behalf of the UK Paediatric BMT WP, of the PD WP and of the SAA WP of the EBMT. In: 56th ASH Annual Meeting and Exposition. 2014, Orlando, FL, USA: American Society of Hematology.
• Haupt R, Dellacasa C, Karner S, Kremer L, Bergeron C, Caruso S, Saraceno D, Morsellino V, Skinner R, Hjorth L. The Survivorship Passport for Long-Term Care of Childhood Cancer Survivors. An Initiative of the European Network for Research on Cancer in Children and Adolescents (ENCCA). In: 46th Congress of The International Society of Paediatric Oncology (SIOP) 2014. 2014, Toronto,Canada: Wiley-Blackwell.
• Brown MC, Levitt GA, Frey E, Bardi E, Haupt R, Hjorth L, Kremer L, Kuehni CE, Lettner C, Mulder RL, Michel G, Skinner R. The views of European clinicians on guidelines for long-term follow-up of childhood cancer survivors. Pediatric Blood & Cancer 2014.
• Bhatnagar N, Wynn R, Velangi M, Vora A, Bonney D, Gibson B, Skinner R, Ewins AM, Amrolia P, Hough R, De La Fuente J, Shaw A, Steward C, Veys P, Samarasinghe S. Upfront matched and mismatched unrelated transplantation in paediatric aplastic anaemia: a United Kingdom multicentre retrospective experience. In: 40th Annual Meeting of the European Group for Blood and Marrow Transplantation. 2014, Milan, Italy: Nature Publishing Group.
• Kremer LCM, Mulder RL, Oeffinger KC, Bhatia S, Landier W, Levitt G, Constine LS, Wallace WH, Caron HN, Armenian SH, Skinner R, Hudson MM. A Worldwide Collaboration to Harmonize Guidelines for the Long-Term Follow-Up of Childhood and Young Adult Cancer Survivors: A Report From the International Late Effects of Childhood Cancer Guideline Harmonization Group. Pediatric Blood & Cancer 2013, 60(4), 543-549.
• Skinner R, Oeffinger KC. Developing international consensus for late effects screening and guidance. Current Opinion in Supportive and Palliative Care 2013, 7(3), 303-308.
• Haupt R, Ortali M, Caruso S, Bagnasco F, Dellacasa C, Karner S, Kremer L, Kienesberger A, Skinner R, Hjorth L. Health Passport for risk adapted follow-up: A joint project of the ENCCA and PanCareSurFup EU consortia. In: European Cancer Congress. 2013, Amsterdam, The Netherlands: Elsevier.
• Mulder RL, Hudson MM, Skinner R, Kremer LCM. Health problems in survivors of childhood cancer: the need for international collaboration in long-term follow-up care. Future Oncology 2013, 9(11), 1667-1670.
• Bate J, Gibson F, Johnson E, Selwood K, Skinner R, Chisholm J. Neutropenic sepsis: prevention and management of neutropenic sepsis in cancer patients (NICE Clinical Guideline CG151). Archives of Disease in Childhood: Education and Practice Edition 2013, 98(2), 73-75.
• Furness CL, Ethell ME, Saha V, Parker C, Vora AJ, Skinner R, Amrolia PJ, Veys P, Lawson S, Potter MN. Outcome of allogeneic haematopoietic stem cell transplant for philadelphia chromosome positive acute lymphoblastic leukaemia in paediatric patients in the era of tyrosine kinase inhibitors and strategies for management of relapse: a UK multicentre study. In: 53rd Annual Scientific Meeting of the British Society for Haematology. 2013, Liverpool, UK: Wiley-Blackwell Publishing Ltd.
• Mulder RL, Kremer LCM, Hudson MM, Bhatia S, Landier W, Levitt G, Constine LS, Wallace WH, van Leeuwen FE, Ronckers CM, Henderson TO, Dwyer M, Skinner R, Oeffinger KC. Recommendations for breast cancer surveillance for female survivors of childhood, adolescent, and young adult cancer given chest radiation: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncology 2013, 14(13), E621-E629.
• Skinner R, Kaplan R, Nathan PC. Renal and Pulmonary Late Effects of Cancer Therapy. Seminars in Oncology 2013, 40(6), 757-773.
• Chagaluka G, Carey P, Banda K, Schwab C, Chilton L, Schwalbe E, Skinner R, Israels T, Moorman A, Molyneux E, Bailey S. Treating childhood acute lymphoblastic leukemia in Malawi. Haematologica 2013, 98(1), e1-e3.
• Peters C, Sykora KW, Veys P, Lankester A, Slatter M, Skinner R, Wachowiak J, Poetschger U. Treosulfan for Conditioning in Children and Adolescents Before Hematopoietic Stem Cell Transplantation (HSCT). In: BMT Tandem Meetings. 2013, Salt Lake City, Utah, USA: Elsevier Inc.
• Firth ER, Davies N, Skinner R. Views of Childhood Cancer Survivors and Their Families on the Provision and Format of a Treatment Summary. Journal of Pediatric Hematology/Oncology 2013, 35(3), 193-196.
• Woolner AF, Davidson A, Skinner R, King D. Evaluation of Infection Control Advice for Patients at Risk of Chemotherapy-Induced Neutropenia in 2 Pediatric Oncology Centers: Cape Town, South Africa, and Newcastle-Upon-Tyne, UK. Pediatric Hematology & Oncology 2012, 29(1), 73-84.
• Pulsipher MA, Skinner R, McDonald GB, Hingorani S, Armenian SH, Cooke KR, Gracia C, Petryk A, Bhatia S, Bunin N, Nieder ML, Dvorak CC, Sung LL, Sanders JE, Kurtzberg J, Baker KS. National Cancer Institute, National Heart, Lung and Blood Institute/Pediatric Blood and Marrow Transplantation Consortium First International Consensus Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: The Need for Pediatric-Specific Long-Term Follow-up Guidelines. Biology of Blood and Marrow Transplantation 2012, 18(3), 334-347.
• Bomken S, Dhir S, Windebank K, Skinner R. Salvage of multiply relapsed Burkitt's non-Hodgkin lymphoma by matched-unrelated donor haematopoietic stem cell transplantation. In: 4th International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkins Lymphoma. 2012, New York, USA: Wiley-Blackwell Publishing Ltd.
• Bate J, Chisholm J, Skinner R, Breuer J, Ramsay M, Wheatley K, Hambleton S, Heath PT. Varicella post-exposure prophylaxis in children with cancer: urgent need for a randomised controlled trial. Archives of Disease in Childhood 2012, 97(9), 853-854.
• Millar M, Zhou W, Skinner R, Pizer B, Hennessy E, Wilks M, Gilbert RE. Accuracy of bacterial DNA testing for central venous catheter-associated bloodstream infection in children with cancer. HEALTH TECHNOLOGY ASSESSMENT 2011, 15(7), XI-+.
• Bailey S, Skinner R, Carey P, Moorman A, Banda K, Banda F, Eden OB, Israels T, Molyneux E. Acute lymphoblastic leukarmia (ALL) in Malawi, progress in the first Malawi ALL protocol. In: Pediatric Blood & Cancer: 43rd Congress of the International Society of Paediatric Oncology (SIOP). 2011, Auckland, New Zealand: John Wiley & Sons, Inc.
• Clarke SA, Skinner R, Guest J, Darbyshire P, Cooper J, Vora A, Urquhart T, Jenney M, Powell J, Eiser C. Clinical outcomes and health-related quality of life (HRQOL) following haemopoietic stem cell transplantation (HSCT) for paediatric leukaemia. CHILD CARE HEALTH AND DEVELOPMENT 2011, 37(4), 571-580.
• Bailey S, Skinner R, Mitra D, Kampondeni S, Knight T, Banda K, Israels T, Molyneux E. CNS LESIONS IN MALAWI, THE SCOPE OF THE PROBLEM. In: PEDIATRIC BLOOD & CANCER. 2011, COMMERCE PLACE, 350 MAIN STREET, MALDEN, MA 02148-529 USA: WILEY PERIODICALS, INC.
• Skinner R. Nephrotoxicity-What Do We Know and What Don't We Know?. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY 2011, 33(2), 128-134.
• Hjorth L, Byrne J, Georgiev A, Haupt R, Kremer L, Levitt G, Pisani P, Skinner R, Sugden E. Pan-European Network for Care of Survivors After Childhood and Adolescent Cancer (PanCare). In: EUROPEAN JOURNAL OF CANCER. 2011, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND: ELSEVIER SCI LTD.
• Bate J, Chisholm J, Heath P, Breuer J, Skinner R, Manley S, Patel S, Wheatley K, Ramsay M, Kearns P, Hambleton S. PEPtalk: post-exposure prophylaxis against varicella in children with cancer. Archives of Disease in Childhood 2011, 96(9), 841-845.
• Ryan SL, Rand V, Schwab C, Morrison H, Matheson E, Minto L, Rahman T, Keavney B, Bown N, Skinner R, Schnittger S, Koref MS, Grossmann V, Kohlmann A, Irving J, Harrison CJ. Ras Signalling Pathway and Novel Target Genes Related to Down Syndrome Contribute to the Development of B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) in iAMP21 Patients. In: BLOOD. 2011, 1900 M STREET. NW SUITE 200, WASHINGTON, DC 20036 USA: AMER SOC HEMATOLOGY.
• Ryan SL, Rand V, Schwab C, Morrison H, Matheson E, Minto L, Rahman T, Keavney B, Bown N, Skinner R, Schnittger S, Santibanez-Koref M, Grossmann V, Kohlmann A, Irving J, Harrison CJ. Ras Signalling Pathway and Novel Target Genes Related to Down Syndrome Contribute to the Development of B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) in iAMP21 Patients. In: 53rd Annual Meeting and Exposition of the American Society of Hematology (ASH). 2011, San Diego, California, USA: American Society of Hematology.
• Haupt R, Pisani P, Garwicz S, Hawkins M, Skinner R, Hjorth L. The Epidemiology of Childhood Cancer Survivors. In: EUROPEAN JOURNAL OF CANCER. 2011, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND: ELSEVIER SCI LTD.
• Whiting P, Phillips B, Beynon R, Harbord R, Burke M, Sterne J, Skinner R. ACCURACY OF CYSTATIN-C FOR THE DETECTION OF ABNORMAL RENAL FUNCTION IN CHILDREN UNDERGOING CHEMOTHERAPY FOR MALIGNANCY: A SYSTEMATIC REVIEW. In: PEDIATRIC BLOOD & CANCER. 2010, DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA: WILEY-LISS.
• Skinner R, Parry A, Price L, Cole M, Craft AW, Pearson ADJ. Glomerular Toxicity Persists 10 Years After Ifosfamide Treatment in Childhood and Is Not Predictable by Age or Dose. Pediatric Blood & Cancer 2010, 54(7), 983-989.
• Clarke SA, Skinner R, Guest J, Darbyshire P, Cooper J, Shah F, Roberts I, Eiser C. Health-related quality of life and financial impact of caring for a child with Thalassaemia Major in the UK. CHILD CARE HEALTH AND DEVELOPMENT 2010, 36(1), 118-122.
• Rees H, Andrews M, Broster S, Nicholson J, Skinner R, Chisholm J, Support Care Grp Childrens Canc &. Influenza vaccination during cancer therapy. ARCHIVES OF DISEASE IN CHILDHOOD 2010, 95(7).
• Reulen RC, Winter DL, Frobisher C, Lancashire ER, Stiller CA, Jenney ME, Skinner R, Stevens MC, Hawkins MM, British Childhood Cancer Survivor Study Steering Group. Long-term Cause-Specific Mortality Among Survivors of Childhood Cancer. JAMA: The Journal of the American Medical Association 2010, 304(2), 172-179.
• Skinner R. Nephrotoxicity of cancer treatment in children. Pediatric Health 2010, 4(5), 519-538.
• Heaney NB, Veys P, Derbyshire P, Skinner R, Vora A, Layden J, Gibson B. Outcomes of paediatric patients with acute lymphoblastic leukaemia receiving two or more allogeneic stem cell transplants. In: BONE MARROW TRANSPLANTATION. 2010, MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND: NATURE PUBLISHING GROUP.
• Phillips B, Skinner R, Lane S, Chisholm J. Challenges in the management of paediatric febrile neutropenia. Current Pediatric Reviews 2009, 5(4), 229-233.
• Hayden JT, Wood KM, Pedler S, Lawson A, Skinner R. Invasive aspergillosis of the small bowel in an infant with acute myeloid leukemia and intestinal obstruction. Pediatric Hematology and Oncology 2009, 26(1), 84-91.
• Bailey S, Skinner R. Paediatric Haematology and Oncology. Oxford, UK: Oxford University Press, 2009.
• Skinner R, Parry A, Price L, Cole M, Craft AW, Pearson ADJ. Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: Relevance of age and dose as risk factors. European Journal of Cancer 2009, 45(18), 3213-3219.
• Gibson F, Hartley J, Lane S, Phillips R, Selwood K, Skinner R, Chisholm J. Reaching A National Consensus On An Approach To Low Risk Febrile Neutropenia: The Challenges of A Delphi Survey. In: EUROPEAN JOURNAL OF ONCOLOGY NURSING. 2009, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND: ELSEVIER SCI LTD.
• Feltbower RG, McNally RJQ, Kinsey SE, Lewis IJ, Picton SV, Proctor SJ, Richards M, Shenton G, Stark DP, Skinner R, Vormoor J, Windebank KP, McKinney PA. The epidemiology of leukaemia and lymphoma in children and young adults from the north of England, 1990-2002. European Journal of Cancer 2009, 45(3), 420-427.
• Skinner R, Velangi M, Bown NP. Donor lymphocyte infusions for post-transplant relapse of refractory anemia with excess blasts and monosomy 7. Pediatric Blood & Cancer 2008, 50(3), 670-672.
• Clarke SA, Eiser C, Skinner R. Health-related quality of life in survivors of BMT for paediatric malignancy: a systematic review of the literature. Bone Marrow Transplantation 2008, 42(2), 73-82.
• Millar MR, Johnson G, Wilks M, Skinner R, Stoneham S, Pizer B, Hemsworth S, Fogarty A, Steward C, Gilbert R, Hennessy EM. Molecular diagnosis of vascular access device-associated infection in children being treated for cancer or leukaemia. CLINICAL MICROBIOLOGY AND INFECTION 2008, 14(3), 213-220.
• Skinner R, Koller K, McIntosh N, McCarthy A, Pizer B. Prevention and management of central venous catheter occlusion and thrombosis in children with cancer. PEDIATRIC BLOOD & CANCER 2008, 50(4), 826-830.
• Skinner R, Hambleton S. Prevention of varicella in children with cancer: Is it time to reconsider our strategy?. Pediatric Blood & Cancer 2008, 51(4), 451-452.
• Selwood K, Pizer B, Gibson B, Skinner R, UKCCSG PONF Supportive Care Grp, MRC CLWP. Vascular access for daunorubicin during childhood acute lymphoblastic leukaemia induction treatment: A UKCCSG supportive care group and MRC childhood leukaemia working party survey. EUROPEAN JOURNAL OF ONCOLOGY NURSING 2008, 12(5), 476-478.
• Stoneham S, Skinner R, Johnson G, Millar M. Diagnosis of central venous access device (CVAD) associated bacteraemia using quantitative 16s rDNA detection. In: 39th Annual Conference of the International Society of Paediatric Oncology SIOP 2007. 2007, Mumbai, India: Pediatric Blood & Cancer: Wiley-Liss, Inc.
• Feltbower RG, McNally RJQ, Kinsey SE, Lewis IJ, Richards M, Shenton G, Windebank KP, Skinner R, McKinney PA. Epidemiology of haematological cancers in children and young adults aged 0-24 years in the north of England. In: ECCO 14. 2007, Barcelona, Spain: European Journal of Cancer Supplements: Elsevier.
• Skinner R, Wallace WHB, Levitt G. Long-term follow-up of children treated for cancer: why is it necessary, by whom, where and how?. Archives of Disease in Childhood 2007, 92(3), 257-260.
• Chinnaswamy G, Chinnaswamy G, Parry AP, Price L, Skinner R. Ototoxicity following platinum based chemotherapy - Is long-term follow up necessary?. In: 39th Annual Conference of the International Society of Paediatric Oncology SIOP 2007. 2007, Mumbai, India: Pediatric Blood & Cancer: Wiley-Liss, Inc.
• Coulthard MG, Skinner R. Should paediatric central lines be aspirated before use?. Archives of Disease in Childhood 2007, 92(6), 517-518.
• Phillips R, Skinner R, Chisholm JC. Treating low-risk febrile neutropenia: Jenny's story. Archives of Disease in Childhood 2007, 92(1), 7-8.
• Phillips B, Selwood K, Lane SM, Skinner R, Gibson F, Chisholm JC. Variation in policies for the management of febrile neutropenia in United Kingdom Children's Cancer Study Group centres. Archives of Disease in Childhood 2007, 92(6), 495-498.
• Velangi MR, Reid MM, Sen S, Skinner R, Taj MM. Hybrid chemotherapy in two children with acute leukemia of ambiguous lineage. Pediatric Blood & Cancer 2006, 46(7), 833-833.
• Skinner R, Wallace WHB, Levitt GA. Long-term follow-up of people who have survived cancer during childhood. Lancet Oncology 2006, 7(6), 489-498.
• Pemberton LC, Levett DL, Skinner R, Hall AG, Hanley JP. Novel mutations in a child with congenital amegakaryocytic thrombocytopenia. British Journal of Haematology 2006, 135(5), 742-743.
• Skinner R. Preventing platinum-induced ototoxicity in children - Is there a potential role for sodium thiosulfate?. Pediatric Blood & Cancer 2006, 47(2), 120-122.
• Piccinelli KJ, Taj M, Lucraft HH, Skinner R. Secondary parotid mucoepidermoid carcinoma after TBI and chemotherapy in childhood AML. Pediatric Blood & Cancer 2006, 47(3), 345-346.
• Skinner R. Best practice in assessing ototoxicity in children with cancer. European Journal of Cancer 2004, 40(16), 2352-2354.
• Bajwa RPS, Skinner R, Windebank KP, Reid MM. Demographic study of leukaemia presenting within the first 3 months of life in the Northern Health Region of England. Journal of Clinical Pathology 2004, 57(2), 186-188.
• Skinner R. Chronic ifosfamide nephrotoxicity in children. In: 7th International Conference on the Long-Term Complications of Treatment of Children and Adolescents for Cancer. 2003, Niagra on the Lake, Canada: Medical and Pediatric Oncology: Wiley-Liss Inc.
• Bajwa RPS, Cant AJ, Abinun M, Flood T, Hodges S, Hale JP, Skinner R. Recombinant tissue plasminogen activator for treatment of hepatic veno-occlusive disease following bone marrow transplantation in children: effectiveness and a scoring system for initiating treatment. Bone Marrow Transplantation 2003, 31(7), 591-597.
• Bailey, S., Roberts, A., Brock, C., Price, L., Craft, A. W., Kilkarni, R., Lee, R. E. J., Skillen, A. W., Skinner, R. Nephrotoxicity in survivors of Wilms' tumours in the North of England. British Journal of Cancer 2002, 87(10), 1092-1098.
• Bajwa RPS, Skinner R, Windebank KP, Wariyar UK, Reid MM. Chemotherapy and marrow transplantation for congenital leukaemia. Archives of Disease in Childhood - Fetal and Neonatal Edition 2001, 84(1), F47-F48.
• Bajwa RPS, Skinner R, Barrett AM. Fibrous pseudotumour of the tunica vaginalis testis. Medical and Pediatric Oncology 2001, 36(6), 665-666.
• Bajwa, R. P. S., Price, L., Roberts, A., Craft, A. W., Skinner, R., Mathias, D. Auditory function is unaffected by treatment with ifosfamide in children and adolescents. Medical and Pediatric Oncology 2000, 35(2), 156.
• Guardiola P, Pasquini R, Dokal I, Ortega JJ, van Weel-Sipman M, Marsh JCW, Ball SE, Locatelli F, Vermylen C, Skinner R, Ljungman P, Miniero R, Shaw PJ, Souillet G, Michallet M, Bekassy AN, Krivan G, Di Bartolomeo P, Heilmann C, Zanesco L, Cahn JY, Arcese W, Bacigalupo A, Gluckman E. Outcome of 69 allogeneic stem cell transplantations for Fanconi anemia using HLA-matched unrelated donors: a study on behalf of the European Group for Blood and Marrow Transplantation. Blood 2000, 95(2), 422-429.
• Eaton S, Skinner R, Hale JP, Pourfarzam M, Roberts A, Price L, Bartlett K. Plasma coenzyme Q₁₀ in children and adolescents undergoing doxorubicin therapy. Clinica Chimica Acta 2000, 302(1-2), 1-9.
• Skinner R, Cotterill SJ, Stevens MCG. Risk factors for nephrotoxicity after ifosfamide treatment in children: a UKCCSG Late Effects Group study. British Journal of Cancer 2000, 82(10), 1636-1645.
• Zeidler C, Welte K, Barak Y, Barriga F, Bolyard AA, Boxer L, Cornu G, Cowan MJ, Dale DC, Flood T, Freedman M, Gadner H, Mandel H, O'Reilly RJ, Ramenghi U, Reiter A, Skinner R, Vermylen C, Levine JE. Stem cell transplantation in patients with severe congenital neutropenia without evidence of leukemic transformation. Blood 2000, 95(4), 1195-1198.
• Wang XN, Taylor PRA, Skinner R, Jackson GH, Proctor SJ, Hedley D, Dickinson AM. T-cell frequency analysis does not predict the incidence of graft-versus-host disease in HLA-matched sibling bone marrow transplantation. Transplantation 2000, 70(3), 488-493.
• Greaves MF, Eden OB, Harrison CJ, Moorman AV, Roman E, Simpson J, Craft A, Hale J, Kernahan J, Reid M, Windebank K, Pearson A, Skinner R, As part of the United Kingdom Childhood Cancer Study Group. The United Kingdom Childhood Cancer Study: objectives, materials and methods. British Journal of Cancer 2000, 82(5), 1073-1102.
• Mital M, Curtis A, Spencer V, Barge D, Skinner R. Delayed engraftment and mixed chimerism after HLA-identical sibling donor BMT in Fanconi anaemia. Bone Marrow Transplantation 1999, 24(2), 201-204.
• English, M. W., Skinner, R., Pearson, A. D. J., Price, L., Wyllie, R., Craft, A. W. Dose-related nephrotoxicity of carboplatin in children. British Journal of Cancer 1999, 81(2), 336-341.
• Bajwa RPS, Skinner R, Flood TJ, Abinun M, Cant AJ. Recombinant tissue plasminogen activator therapy for hepatic veno-occlusive disease. Bone Marrow Transplantation 1999, 23(Supplement 1), S223-S223.
• Wang XN, Skinner R, Jackson GH, Proctor SJ, Dickinson AM. Role of T cell frequency analysis in predicting acute graft- versus-host disease in HLA matched sibling bone marrow transplantation. Bone Marrow Transplantation 1999, 23(Supplement 1), S97-S97.
• MacLean FR, Skinner R, Hall AG, English M, Pearson ADJ. Acute changes in urine protein excretion may predict chronic ifosfamide nephrotoxicity: a preliminary observation. Cancer Chemotherapy and Pharmacology 1998, 41(5), 413-416.
• Skinner, R., Pearson, A. D. J., English, M. W., Price, L., Wyllie, R. A., Coulthard, M. G., Craft, A. W. Cisplatin dose rate as a risk factor for nephrotoxicity in children. British Journal of Cancer 1998, 77(10), 1677-1682.
• Broadhead C, Walker D, Skinner R, Simmons NL. Differential cytotoxicity of ifosfamide and its metabolites in renal epithelial cell cultures. Toxicology in Vitro 1998, 12(3), 209-217.
• Crooks BNA, Abinun M, Angus B, Cant AJ, Flood TJ, Skinner R. Large cell anaplastic lymphoma & parainfluenza in severe combined immunodeficiency cured by bone marrow transplantation. Molecular Immunology 1998, 35(11-12), 778-778.
• Yule, S., Skinner, R., English, M. W., Cole, M., Pearson, A. D. J., Lucraft, H. H., Craft, A. W. Outcome and toxicity of an ifosfamide-based soft tissue sarcoma treatment protocol in children. The importance of local therapy. Sarcoma 1998, 2(3-4), 171-177.
• Skinner, R., Wright, C. M., Craft, A. W. How to organise the paediatric MRCP (UK) part II clinical examination. Archives of Disease in Childhood 1997, 76(6), 545-548.
• Ashraf, M. S., Skinner, R., English, M. W., Craft, A. W., Pearson, A. D. J. Late reversibility of chronic ifosfamide-associated nephrotoxicity in a child. Medical and Pediatric Oncology 1997, 28(1), 62-64.
• English, M. W., Skinner, R., Pearson, A. D. J., Price, L., Wyllie, R., Craft, A. W. The influence of ifosfamide scheduling on acute nephrotoxicity in children. British Journal of Cancer 1997, 75(9), 1356-1359.
• Davies SM, Harris RE, vanWeelSipman MH, Dokal I, Skinner R, Casper JT, Kurtzberg J, Smith F, Karanes C, Chen A, Cairo M, Yeager AM, DeFor T, Wagner JE. Unrelated donor stem cell transplant for Fanconi anemia: Multicenter report of forty-nine cases. Blood 1997, 90(10 Part 1 Supplement 1), 474-474.
• Skinner R, Appleton AL, Sprott MS, Barer MR, Magee JG, Darbyshire PJ, Abinun M, Cant AJ. Disseminated BCG infection in severe combined immunodeficiency presenting with severe anaemia and associated with gross hypersplenism after bone marrow transplantation. Bone Marrow Transplantation 1996, 17(5), 877-880.
• Boddy, A. V., English, M., Pearson, A. D. J, Idle, J., Skinner, R. Ifosfamide nephrotoxicity: Limited influence of metabolism and mode of administration during repeated therapy in paediatrics. European Journal of Cancer Part A 1996, 32(7), 1179-1184.
• Bailey, S., Skinner, R., Lucraft, H. H., Perry, R. H., Todd, N., Pearson, A. D. J. Pineal tumours in the north of England 1968-93. Archives of Disease in Childhood 1996, 75(3), 181-185.
• Skinner, R., Pearson, A. D. J., English, M., Price, L., Wyllie, R., Coulthard, M. G., Craft, A. W. Risk factors for ifosfamide nephrotoxicity in children. The Lancet 1996, 348(9027), 578-580.
• Skinner, R., Cole, M., Pearson, A. D. J., Coulthard, M. G., Craft, A. W. Specificity of pH and osmolality of early morning urine sample in assessing distal renal tubular function in children: Results in healthy children. British Medical Journal - Clinical Research Edition 1996, 312(7042), 1337-1338.
• Wright, N. B., Skinner, R., Lee, R. E. J., Craft, A. W. Osteogenic sarcoma of the neural arch. Pediatric Radiology 1995, 25(1), 62-63.
• Skinner, R., Pearson, A. D. J., Craft, A. W. Ifosfamide nephrotoxicity in children. Medical and Pediatric Oncology 1994, 22(2), 153-154.
• Skinner R, Cole M, Pearson ADJ, Keir MJ, Price L, Wyllie RA, Coulthard MG, Craft AW. Inaccuracy of glomerular-filtration rate estimation from height/plasma creatinine ratio. Archives of Disease in Childhood 1994, 70(5), 387-390.
• Skinner, R., Sharkey, I. M., Pearson, A. D. J., Craft, A. W. Ifosfamide, mesna, and nephrotoxicity in children. Journal of Clinical Oncology 1993, 11(1), 173-190.
• Wright, N. B., Skinner, R., Lee, R. E. J., Craft, A. W. Myxoid liposarcoma of the porta hepatis in childhood. Pediatric Radiology 1993, 23(8), 620-621.
• Clemons MJ, Clemons KR, Skinner R. Medicine- the hearing profession?. British Medical Journal 1992, 305(6868), 1568-1569.
• Skinner, R., Pearson, A. D. J., Price, L., Coulthard, M. G., Craft, A. W. The influence of age on nephrotoxicity following chemotherapy in children. British Journal of Cancer 1992, 66(Supplement 18), 30-S35.
• Skinner, R., Pearson, A. D. J., Coulthard, M. G., Skillen, A. W. , Hodson, A. W., Goldfinch, M. E., Gibb, I., Craft, A. W. Assessment of chemotherapy-associated nephrotoxicity in children with cancer. Cancer Chemotherapy and Pharmacology 1991, 28(2), 81-92.
• MORRIS K, SKINNER R, KEIR M, PALMER J, LAMBERT H, PEARSON A, COULTHARD M. PROBLEMS WITH THE SINGLE INJECTION METHOD FOR THE MEASUREMENT OF THE GLOMERULAR-FILTRATION RATE IN MAN. CLINICAL SCIENCE 1991, 81(6), 831-832.
• Skinner R, Lambert HJ. Fractures of long bones occurring in neonatal intensive therapy units. British Medical Journal 1990, 301(6756), 873-873.
• Skinner, R., Pearson, A. D. J., Price, L., Coulthard, M. G., Craft, A. W. Nephrotoxicity after ifosfamide. Archives of Disease in Childhood 1990, 65(7), 732-738.
• Skinner, R., Pearson, A. D. J., Amineddine, H. A., Mathias, D. B., Craft, A. W. Ototoxicity of cisplatinum in children and adolescents. British Journal of Cancer 1990, 61(6), 927-931.
• Skinner, R., Pearson, A. D. J., Price, L., Cunningham, K., Craft, A. W. Hypophosphataemic rickets after ifosfamide treatment in children. British Medical Journal 1989, 298(6687), 1560-1561.
• Skinner, R., Pearson, A. D. J., Price, L., Coulthard, M. G., Craft, A. W. Nephrotoxicity of ifosfamide in children. The Lancet 1989, 334(8655), 159.
• Skinner, R., Pearson, A. D. J., Amineddine, H. A., Mathias, D. B., Craft, A. W. Ototoxicity of cis-platinum. British Journal of Cancer 1988, 58(2), 261.
• Skinner R, Ferner RE. Acute renal failure without acute intravascular haemolysis after Nomifensine overdosage. Human Toxicology 1986, 5(4), 279-280.